<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02867501</url>
  </required_header>
  <id_info>
    <org_study_id>2016-00375</org_study_id>
    <nct_id>NCT02867501</nct_id>
  </id_info>
  <brief_title>Venous Distension in Patients With Aneurysmatic Arterial Disease</brief_title>
  <official_title>Venous Distension in Patients With Aneurysmatic Arterial Disease Compared to the Venous Distension in Patients With Arterial Occlusive Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Baselland Bruderholz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Baselland Bruderholz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess if venous distension in patients with aneurysmatic
      arteriopathy is higher compared to patients with peripheral arterial occlusive disease (PAOD)
      and in controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with aortic aneurysm and patients with PAOD and Controls will be investigated in the
      following manner: Duplexsonography with assessment of the arterial diameters in the aorta and
      leg arteries. Duplexsonography with assessment of venous reflux in proximal and deep veins of
      both legs Duplexsonography testing of venous distension in the common femoral vein, the great
      saphenous vein and the femoral vein.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">March 28, 2017</completion_date>
  <primary_completion_date type="Actual">March 28, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Venous distension of &gt; 27% in patients with aneurysmatic arterial disease</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">98</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <condition>Popliteal Artery Aneurysm</condition>
  <condition>Peripheral Arterial Occlusive Disease</condition>
  <condition>Vascular Diseases</condition>
  <condition>Aortic Diseases</condition>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>Aneurysmatic disease</arm_group_label>
    <description>Patients with dilatative arteriopathy (DA) the aortic diameter must be &gt; 3 cm or the popliteal artery diameter &gt; 1.5 cm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peripheral arterial occlusive disease</arm_group_label>
    <description>Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) &lt; 0.9 and positive criteria in the Edinburgh questionnaire.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Control group of age matched persons without PAOD (ABI &gt; 0.9) and without DA.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The population is selected from patients of the angiologic clinic Baselland Bruderholz
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with dilatative arteriopathy (DA) the aortic diameter must be &gt; 3 cm or the
             popliteal artery diameter &gt; 1.5 cm

          -  Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index
             (ABI) &lt; 0.9 and positive criteria in the Edinburgh questionnaire

          -  Patients able to give informed consent

          -  Control group of age matched persons without PAOD (ABI &gt; 0.9) and without DA

        Exclusion Criteria:

          -  Impossibility to stand

          -  Diabetes

          -  No given informed consent

          -  Persons and patients &lt; 18 years old

          -  Acute deep venous thrombosis

          -  History of deep venous thrombosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Jeanneret C, Baldi T, Hailemariam S, Koella C, Gewaltig J, Biedermann BC. Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography. Br J Surg. 2007 Apr;94(4):449-56.</citation>
    <PMID>17262753</PMID>
  </reference>
  <reference>
    <citation>Jeanneret C, JÃ¤ger KA, Zaugg CE, Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vasc Endovasc Surg. 2007 Aug;34(2):236-42. Epub 2007 May 24.</citation>
    <PMID>17524680</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2016</study_first_posted>
  <last_update_submitted>March 31, 2017</last_update_submitted>
  <last_update_submitted_qc>March 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Baselland Bruderholz</investigator_affiliation>
    <investigator_full_name>Janis Christian Bartelt</investigator_full_name>
    <investigator_title>intern</investigator_title>
  </responsible_party>
  <keyword>venous distension</keyword>
  <keyword>venous reflux</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Aortic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

